| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9d0c82c6254d5b4bec8c96e45c9db7b |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 |
| filingDate |
2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d4fba61812cd0f14f31d29ab8cb79d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d8ce70bdd4c35141a0eafc0c02dd8f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a38de7cb1342e85a20ff787d0b3e7816 |
| publicationDate |
2013-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2013245162-A |
| titleOfInvention |
Drugs used to maintain engraftment of transplanted heart, transplanted blood vessels, or transplanted kidneys among allogeneic species |
| abstract |
[PROBLEMS] To provide a novel drug capable of maintaining the engraftment of transplanted heart or blood vessel between the same species over a long period of time. A drug according to the present invention is used for maintaining the engraftment of transplanted heart or transplanted blood vessel among allogeneic species, and contains a DNAM-1 neutralizing antibody as an active ingredient. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180135028-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11059888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017183665-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017183665-A1 |
| priorityDate |
2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |